最新消息

2014-04-16

HKSH Pioneer Clinical Study for Peanut Allergy in Hong Kong - A New Customized Desensitization Treatment for Peanut Allergic Patient

A pilot study conducted by Hong Kong Sanatorium & Hospital’s Allergy Centre has found that a dual treatment approach combining the use of anti-IgE (omalizumab, a drug that reduces allergic reaction) and oral desensitization has been successful in increasing tolerance for peanuts in patients suffering from peanut allergy. Even if they accidentally ingest peanut-containing foods, allergic reaction will not appear easily, thus their lives are protected.

Please click here for more information. 

 


慎防詐騙提示:近日接獲有公眾人士指稱收到冒充養和醫院的電話,並通知有醫療文件未領取,此類通訊均為冒充來電,切勿回覆或提供個人資料。 公眾人士請慎防冒充養和醫療集團或其成員包括養和醫院、養和醫健、養和東區醫療中心 、養和癌症中心 以及各關聯公司名義的通訊 (虛假網站、電郵或語音來電等)。如有懷疑,切勿提供個人資料,並致電2572 0211與本集團聯絡。

find us on     YouTube     Instagram     Wechat